Version 1
: Received: 16 June 2021 / Approved: 17 June 2021 / Online: 17 June 2021 (09:17:59 CEST)
How to cite:
Elalamy, I.; Falanga, A.; Girvalaki, C.; Monreal, M.; Easaw, J.C.; Young, A. How Well do European Patients Understand Cancer-Associated Thrombosis? A Patient Survey. Preprints2021, 2021060453. https://doi.org/10.20944/preprints202106.0453.v1
Elalamy, I.; Falanga, A.; Girvalaki, C.; Monreal, M.; Easaw, J.C.; Young, A. How Well do European Patients Understand Cancer-Associated Thrombosis? A Patient Survey. Preprints 2021, 2021060453. https://doi.org/10.20944/preprints202106.0453.v1
Elalamy, I.; Falanga, A.; Girvalaki, C.; Monreal, M.; Easaw, J.C.; Young, A. How Well do European Patients Understand Cancer-Associated Thrombosis? A Patient Survey. Preprints2021, 2021060453. https://doi.org/10.20944/preprints202106.0453.v1
APA Style
Elalamy, I., Falanga, A., Girvalaki, C., Monreal, M., Easaw, J.C., & Young, A. (2021). How Well do European Patients Understand Cancer-Associated Thrombosis? A Patient Survey. Preprints. https://doi.org/10.20944/preprints202106.0453.v1
Chicago/Turabian Style
Elalamy, I., Jacob C. Easaw and Annie Young. 2021 "How Well do European Patients Understand Cancer-Associated Thrombosis? A Patient Survey" Preprints. https://doi.org/10.20944/preprints202106.0453.v1
Abstract
Ongoing concerns regarding the morbidity and mortality from cancer-associated thrombosis led the European Cancer Patient Coalition (ECPC), the voice of cancer patients across Europe, to create a pan-European cancer-associated awareness patient survey to assess CAT knowledge among a large population of patients with cancer. The ECPC survey represents the largest of its kind amongst patients/caregivers with CAT and identified significant gaps in patient awareness and knowledge of CAT. It also identified a need for educational CAT-related discussions and interventions between healthcare professionals and patients with cancer and their caregivers. The aim of this paper is to highlight these gaps and to provide healthcare professionals with awareness of what information should be shared with patients/caregivers as well as how and when that information should be provided. Notably, the importance of providing information on CAT risk and risk factors, how to reduce their risk of CAT, the role of anticoagulant prophylaxis and treatment (short- and long-term) including possible side-effects, and finally how to early identify CAT symptoms. Here we outline what type of information should be provided, as well as when and how to best discuss CAT with our oncology patients and their caregivers along the cancer care continuum, to reduce the risk of CAT and associated complications with a goal of improving patient outcomes.
Keywords
Cancer-associated thrombosis; survey; anticoagulant; cancer patients
Subject
Medicine and Pharmacology, Immunology and Allergy
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
